Brief: 10X Genomics Q1 Revenue USD 150.8 Million Vs. IBES Estimate USD 146.4 Million
07/05/2026 21:05
May 07 (Reuters) - 10X Genomics Q1 gross margin 70%. Q1 net income USD -13.5 million Q1 operating income USD -17 million outlook FY revenue USD 600-625 million vs. IBES estimate USD 613.1 million
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences